Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin-Reference-Cited by-同舟云学术

Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin

Published:1996-08 Issue:4 Volume:23 Page:335-343
ISSN:0303-6987
Container-title:Journal of Cutaneous Pathology
language:en
Short-container-title:J Cutan Pathol

Author:

Talve Lauri Arvo Ilmar,Collan Yrjo Urho Ilmari,Ekfors Tauno Olavi

Publisher

Wiley

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0560.1996.tb01307.x/fullpdf

Reference45 articles.

1. Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma

2. The multi-center morphometric mammary carcinoma project (MMMCP) in the netherlands: Value of morphometrically assessed proliferation and differentiation

3. Morphometry in Human Transitional Cell Bladder Cancer

4. Nuclear quantitative grading by discriminant analysis of renal cell carcinoma samples. A patient survival evaluation

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRAME expression in cutaneous melanoma does not correlate with disease‐specific survival;Journal of Cutaneous Pathology;2023-07-10

2. Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis;International Journal of Molecular Sciences;2022-05-25

3. Proliferative activity in melanocytic nevi from patients grouped by age with clinical follow-up;Journal of Cutaneous Pathology;2015-11-17

4. Prognostic Factors in Cutaneous Melanoma;Pathology of Melanocytic Nevi and Melanoma;2014

5. Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma;Cancer Biomarkers;2013-12-18